Striking increase in circulating hepatocyte growth factor during enoxaparin-anticoagulated haemodialysis [4]

Nephrology Dialysis Transplantation

Volumn 18, Issue 8, 2003, Pages 1680-1682

  Borawski, Jacek ^a   Naumnik, Beata ^a   Myśliwiec, Michał ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CYTOKINE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; SCATTER FACTOR;

ANALYSIS OF VARIANCE; ANGIOGENESIS; ANTICOAGULATION; BOLUS INJECTION; CONCENTRATION RESPONSE; CORRELATION COEFFICIENT; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LETTER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANTICOAGULANTS; ENOXAPARIN; HEPATOCYTE GROWTH FACTOR; HUMANS; RENAL DIALYSIS;

EID: 0043166454     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg217     Document Type: Letter

References (5)

1. Borawski J, Mysliwiec M. Serum hepatocyte growth factor is associated with viral hepatitis, cardiovascular disease, erythropoietin treatment, and type of heparin in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 637-644
2. Malatino LS, Mallamaci M, Benedetto FA et al. Hepatocyte growth factor predicts survival and relates to inflammation and intima, media thickness in end-stage renal disease. Am J Kidney Dis 2000; 36: 945-952
3. Matsumori A, Ono K, Okada M, Miyamoto T, Sato Y, Sasayama S. Immediate increase in circulating hepatocyte growth factor/scatter factor by heparin. J Mol Cell Cardiol 1998; 30: 2145-2149
4. Seidel C, Hjorth-Hansen H, Bendz B et al. Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individuals. Br J Haematol 1999; 105: 641-647
5. Rampino T, Libetta C, de Simone W et al. Hemodialysis stimulates hepatocyte growth factor release. Kidney Int 1998; 53: 1382-1388